Information Empowers Patients With GI Malignancies

KELLY JOHNSON @OncKelly
Wednesday, December 09, 2015
Talk about this article with nurses and others in the oncology community in the General Discussions Oncology Nursing News discussion group.
John L. Marshall, MD

John L. Marshall, MD

Entering through the giant, inflatable colon, dozens of patients, caregivers, family members, and providers gathered at the Georgetown University Hotel and Conference Center in Washington, DC, December 5 for the symposium, “Fighting a Smarter War Against Cancer.”

The symposium featured a live taping of CURE Connections panel discussions covering support, disease-specific sessions, nutrition and more.

With many of his own patients in the audience, John L. Marshall, MD, began the first discussion on the importance of building a support system, or as he described it, a “village.”

“You’re walking through this mirror and now you’re on the other side. You’re in this new club. There are a lot of people in the club, but you never thought that you’d be in the club,” said Marshall, director of Ruesch Center for the Cure of Gastrointestinal Cancers. “There is entirely new language, priorities, and your life just changes at that moment.”

Looking for Guidance
Exactly one month after an oncologist told her that there was an 80% chance she was free of colon cancer, Anastasia Traylor sat in front of a panel of patients, survivors and doctors, wondering why she was there.

“It’s weird because here I am at a cancer conference and I don’t feel sick,” she said. “It’s really hard to think of myself as sick. I don’t want to think of myself as only 80%.”

Traylor was diagnosed with stage II colorectal cancer and had surgery November 5 to remove a portion of her colon. Last week, her oncologist told her that there is a 20% chance of recurrence and gave her the option to receive chemotherapy—a choice that she hoped the Sixth Annual Ruesch Center Symposium would help her make.

“I have to make the decision this week,” she said. “My oncologist said that this was going to be very informative, and I could meet some other patients that went through the same decision-making process and went through the same chemo.”

Patient–Provider Communication
Three patient advocates with varying types and stages of gastrointestinal cancers described their experiences during the appointment of their primary diagnoses.

“In that initial moment after diagnosis, for me, I didn’t want information,” Alli Macken said. “I was in a fog for at least the first week.”

For Traylor, she said that information has been the most important part of her process.

“Those first few hours in the emergency room when I didn’t know anything were the scariest of my life,” she recalled. “But once the information started flowing—even though it wasn’t necessarily good information—I felt like I was in control and it calmed me down.”

After the other patients gave their personal accounts, Marshall reaffirmed that physicians struggle with delivering the news of a cancer diagnosis as well.

“We don't like giving bad news,” he said. “We personally have to get prepared, too.”

Marshall added that while studies show that having a positive attitude may reduce side effects and improve outcomes, providers shouldn’t push patients to feel happy.

“It’s important, and we do try to emphasize positive thinking, but there are some people who just feel bad,” he said. “We have to forgive those people who find themselves in a pit sometimes. I don’t want people to think it’s their fault when they’re down.”

The discussion was followed by a series of breakout sessions focusing on specific cancers including colorectal, pancreatic, liver and biliary, and upper gastrointestinal.

Freda Omaswa, from the University of British Columbia, shared her unique account of being a provider as well as a patient with colorectal cancer.

Emphasizing the value of a multidisciplinary approach, she said that her experience with the disease will make her a better doctor.

Meeting Patients’ Dietary Needs
In another session, Rachel Wong, from the Lombardi Comprehensive Cancer Center, sat with her patient, Ann Hagemann, to talk about nutrition in cancer.

Hagemann had experienced symptoms of gastroesophageal reflux disease (GERD) for a few years, which was treated with over-the-counter medications, before she eventually couldn’t swallow anything. She was diagnosed with a malignant tumor at the gastroesophageal junction between the esophagus and stomach.

While sitting in the waiting room, she noticed a placard on the wall for a dietitian.

“I wanted strategies for how I could eat anything at that point,” she said. “Rachel taught me that the chemotherapy’s job was to kill all of the cancer cells. My job was to build strong cells.”

Wong said that every patient is unique in their dietary needs, but she generally advises against fatty or fried foods, acidic foods, flaxseeds, and corn, which can cause distress after surgery or treatment.

Many patients with gastrointestinal cancer experience weight loss, and Wong added that she recommends sources of quality calories, including avocados, olive oil and nut butters, which can be easier on the digestive system than nuts.

When asked about the importance of consulting a dietitian during the cancer journey, Wong said that making the challenges smaller makes the goals feasible for patients.

“Anybody will have difficulty changing if they don’t understand that they need to make changes,” she said.

The symposium kicked off last Thursday with policy briefing on funding for gastrointestinal cancers and ended with a review of advances in research and treatment of the disease, including immunotherapy and molecular profiling.

On Friday, there was a session on risk factors and treatment options for patients under age 50 with colorectal cancer followed by a discussion between experts, economists, payers and patients regarding defining quality cancer care in terms of health care costs.

Patients flocked around Marshall for pictures and embraces on Saturday as he concluded the symposium.

After considering the information she received from the symposium along with her family’s input, Traylor decided to go forward with chemotherapy.

“I’m going to do it, given the situation that I’m in,” she said. “I have two kids and they’re really young, I’m a healthy person, and I know what normal feels like. I can’t really flip a coin on this.”



Talk about this article with nurses and others in the oncology community in the General Discussions Oncology Nursing News discussion group.
Related Articles
By: Insights From: Samuel J. Klempner, MD, The Angeles Clinic and Research Institute; Cedar Sinai Medical Center; Alice Beers, RN, BSN, OCN, MedStar Health System
External Resources

MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc
OncNurse Resources

Blogs
Continuing Education
Discussions
Web Exclusives


About Us
Advertise
Advisory Board
Careers
Contact Us
Privacy Policy
Terms & Conditions
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright OncNursing 2006-2017
Intellisphere, LLC. All Rights Reserved.